Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
New England Journal of Medicine · 10.04.2025 · 392 (14) · 1396-1405
DOI: 10.1056/nejmoa2500366 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 10.04.2025. Verfasst von Sergio Raposeiras-Roubin und 50 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Heart Failure, Sodium-Glucose Transporter 2 Inhibitors, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid.
- Cardiology Department, University Hospital Álvaro Cunqueiro and Instituto de Investigación Sanitaria Galicia Sur, Vigo, Spain.
- University of Santiago de Compostela, Santiago de Compostela, Spain.
- Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares, Madrid.
- Cardiology Department, University Clinical Hospital of Valladolid, Valladolid, Spain.
- Cardiology Department, University Hospital Son Espases and Instituto de Investigación Sanitaria Islas Baleares, Palma de Mallorca, Spain.
ORCID-Profile: Xavier Rossello, Victoria Vilalta, Rafael Romaguera, Eduardo Alegría-Barrero
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Raposeiras-Roubin, S., Amat-Santos, I. J., Rossello, X., González Ferreiro, R., González Bermúdez, I., Lopez Otero, D., Nombela-Franco, L., Gheorghe, L., Diez, J. L., Baladrón Zorita, C., Baz, J. A., Muñoz García, A. J., Vilalta, V., Ojeda-Pineda, S., de la Torre Hernández, J. M., Cordoba Soriano, J. G., Regueiro, A., Bordes Siscar, P., Salgado Fernández, J., …, & DapaTAVI Investigators (2025). Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation. New England Journal of Medicine, 392(14), 1396-1405. https://doi.org/10.1056/nejmoa2500366
Vancouver
Raposeiras-Roubin S, Amat-Santos IJ, Rossello X, González Ferreiro R, González Bermúdez I, Lopez Otero D, et al. Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation. New England Journal of Medicine. 2025;392(14):1396-1405. doi:10.1056/nejmoa2500366
BibTeX
@article{RaposeirasRoubin2025,
author = {Raposeiras-Roubin, Sergio and Amat-Santos, Ignacio J and Rossello, Xavier and González Ferreiro, Rocío and González Bermúdez, Inmaculada and Lopez Otero, Diego and Nombela-Franco, Luis and Gheorghe, Livia and Diez, Jose L and Baladrón Zorita, Carlos and Baz, José A and Muñoz García, Antonio J and Vilalta, Victoria and Ojeda-Pineda, Soledad and de la Torre Hernández, José M and Cordoba Soriano, Juan G and Regueiro, Ander and Bordes Siscar, Pascual and Salgado Fernández, Jorge and Garcia Del Blanco, Bruno and Martín-Reyes, Roberto and Romaguera, Rafael and Moris, César and García Blas, Sergio and Franco-Peláez, Juan A and Cruz-González, Ignacio and Arzamendi, Dabit and Romero Rodríguez, Nieves and Díez-Del Hoyo, Felipe and Camacho Freire, Santiago and Bosa Ojeda, Francisco and Astorga Burgo, Juan C and Molina Navarro, Eduardo and Caballero Borrego, Juan and Ruiz Quevedo, Valeriano and Sánchez-Recalde, Ángel and Peral Disdier, Vicente and Alegría-Barrero, Eduardo and Torres-Llergo, Javier and Feltes, Gisela and Fernández Díaz, José A and Cuellas, Carlos and Jiménez Britez, Gustavo and Sánchez-Rubio Lezcano, Juan and Barreiro-Pardal, Cristina and Núñez-Gil, Iván and Abu-Assi, Emad and Iñiguez-Romo, Andrés and Fuster, Valentín and Ibáñez, Borja and DapaTAVI Investigators, DapaTAVI Investigators},
title = {Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {14},
pages = {1396--1405},
doi = {10.1056/nejmoa2500366}
}
EUVIMED